世界中医药
文章摘要
引用本文:汤 玲 王冬梅 顾慧霞 刘 丽 王燕霞 贺稚平.肌瘤内消丸治疗子宫肌瘤临床疗效分析[J].世界中医药,2012,7(5):.  
肌瘤内消丸治疗子宫肌瘤临床疗效分析
Clinical Theraputic Effect of Zhongliu Neixao Pill on Uterine Fibroids
投稿时间:2011-12-13  
DOI:
中文关键词:  子宫肌瘤  肌瘤内消丸  气虚血瘀
English Keywords:Uterine fibroids  Zhongliu Neixao Pill  Qi deficiency and blood stasis
基金项目:北京中医药大学中青年教师资助项目(编号:JYB22-JS064)
作者单位
汤 玲 王冬梅 顾慧霞 刘 丽 王燕霞 贺稚平 北京中医药大学东直门医院100700 
摘要点击次数: 1337
全文下载次数: 1183
中文摘要:
      目的:观察肌瘤内消丸治疗子宫肌瘤临床疗效。方法:将60例确诊为子宫肌瘤的患者随机分为2组,治疗组30例和对照组30例。治疗组给予肌瘤内消丸治疗,对照组给予米非司酮,疗程均为3个月。3个月后对比疗效。结果:治疗组患者总有效率86.67%,对照组患者治疗总有效率63.33%,两者比较有统计学意义,P<0.05。结论:肌瘤内消丸治疗子宫肌瘤临床效果显著,值得临床推广。
English Summary:
      To observe clinical theraputic effect of Zhongliu Neixao Pill on uterine fibroids.Methods: Sixty patients diagnosed with uterine fibroids were randomly divided into 2 groups: the treatment group (30 cases)and the control group (30 cases).The treatment group received Zhongliuneixaowan,and the control group received mifepristone.The clinical effect was compared after 3 months clinical course.Results:The effect rate of Treatment group is 86.67%,and the control group is 63.33%.Conclusion:Clinical effect of Zhongliuneixaowan on Uterine fibroids is more significant than mifepristone desere the clinical expansion.
查看全文  查看/发表评论  下载PDF阅读器